Healionics Granted US Patent for STARgraft Technology

Healionics Corporation, a developer of synthetic biomaterial-based medical devices, announced that the US Patent and Trademark Office has issued a patent titled, “Vascular Grafts and Method for Preserving Patency of the Same”. This patent relates to Healionics’ STARgraft vascular graft, designed to provide a safer and more reliable means of bloodstream access for kidney failure patients needing dialysis.